Locomotion status and costs in destructive rheumatoid arthritis : a comprehensive study of 82 patients from a population of 13,000.
Clinical manifestations (locomotion score) and annual costs were studied in a population-based cohort of 82 patients with rheumatoid arthritis fulfilling five to eight American Rheumatological Association's (ARA) criteria.
The total costs were SEK 4.9 million: respectively 56 and 44 percent direct and indirect costs.
The costs were correlated with total, as well as subjective and objective, locomotion scores, which assess separately impairment, disability, and handicap from the disease (WHO 1980).
Patients below 65 years had higher costs-predominantly as an indirect cost due to loss of work-than older patients.
Mots-clés Pascal : Polyarthrite rhumatoïde, Rhumatisme inflammatoire, Chronique, Maladie autoimmune, Système ostéoarticulaire pathologie, Homme, Exploration, Locomotion, Capacité fonctionnelle, Analyse coût, Economie santé
Mots-clés Pascal anglais : Rheumatoid arthritis, Inflammatory joint disease, Chronic, Autoimmune disease, Diseases of the osteoarticular system, Human, Exploration, Locomotion, Functional capacity, Cost analysis, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 92-0306609
Code Inist : 002B15D. Création : 199406.